Virotherapy, gene transfer and immunostimulatory monoclonal antibodies

1
Highlight from this issue http://dx.doi.org/10.4161/onci.22839; Correspondence to: Andriy Nemchenko; www.info2visual.com OncoImmunology 1:8, 1226–1226; November 2012; © 2012 Landes Bioscience INFOGRAPHIC Infographic from: J.I. Quetglas, L.B. John, M.H. Kershaw, L. Alvarez-Vallina, I. Melero, P.K. Darcy and C. Smerdou. Virotherapy, gene transfer and immunostimulatory monoclonal antibodies; This issue, pp. 1344–54. 1226 OncoImmunology Volume 1 Issue 8

Transcript of Virotherapy, gene transfer and immunostimulatory monoclonal antibodies

Page 1: Virotherapy, gene transfer and immunostimulatory monoclonal antibodies

Hig

hlig

ht fr

om th

is iss

ue

http://dx.doi.org/10.4161/onci.22839; Correspondence to: Andriy Nemchenko; www.info2visual.com

OncoImmunology 1:8, 1226–1226; November 2012; © 2012 Landes Bioscience

INfOgraphIc

Infographic from: J.I. Quetglas, L.B. John, M.H. Kershaw, L. Alvarez-Vallina, I. Melero, P.K. Darcy and C. Smerdou. Virotherapy, gene transfer and immunostimulatory monoclonal antibodies; This issue, pp. 1344–54.

1226 OncoImmunology Volume 1 Issue 8

Ex Vivo Oncolytic Virotherapy with Myxoma Virus Arms ......Original Article Ex Vivo Oncolytic Virotherapy with Myxoma Virus Arms Multiple Allogeneic Bone Marrow Transplant Leukocytes

Ex Vivo Oncolytic Virotherapy with Myxoma Virus Arms ......Original Article Ex Vivo Oncolytic Virotherapy with Myxoma Virus Arms Multiple Allogeneic Bone Marrow Transplant Leukocytes

Cationic Liposomes Extend the Immunostimulatory Effect of CpG … · Cationic Liposomes Extend the Immunostimulatory Effect of CpG Oligodeoxynucleotide against Burkholderia pseudomallei

Cationic Liposomes Extend the Immunostimulatory Effect of CpG … · Cationic Liposomes Extend the Immunostimulatory Effect of CpG Oligodeoxynucleotide against Burkholderia pseudomallei

Lipid-derived nanoparticles for immunostimulatory … · Lipid-derived nanoparticles for immunostimulatory RNA adjuvant delivery ... Michael Goldbergb, ... Contributed by Robert Langer,

Lipid-derived nanoparticles for immunostimulatory … · Lipid-derived nanoparticles for immunostimulatory RNA adjuvant delivery ... Michael Goldbergb, ... Contributed by Robert Langer,

Polyneuropathy associated with monoclonal … studies of monoclonal gammopathy, IgG M ... polyneuropathy associated with monoclonal ... besides a monoclonal protein (M-protein) IgM

Polyneuropathy associated with monoclonal … studies of monoclonal gammopathy, IgG M ... polyneuropathy associated with monoclonal ... besides a monoclonal protein (M-protein) IgM

Structural characterization and immunostimulatory activity ...

Structural characterization and immunostimulatory activity ...

Nanoparticle Delivery of Immunostimulatory Agents for Cancer … · 1 Nanoparticle Delivery of Immunostimulatory Agents for Cancer Immunotherapy Jia Zhuang, 1 1Maya Holay , Joon Ho

Nanoparticle Delivery of Immunostimulatory Agents for Cancer … · 1 Nanoparticle Delivery of Immunostimulatory Agents for Cancer Immunotherapy Jia Zhuang, 1 1Maya Holay , Joon Ho

Review Immune Suppression during Oncolytic Virotherapy for ... · Immune Suppression during Oncolytic Virotherapy for High-Grade Glioma; Yes or No? Carolien A.E. Koks1 , Steven De

Review Immune Suppression during Oncolytic Virotherapy for ... · Immune Suppression during Oncolytic Virotherapy for High-Grade Glioma; Yes or No? Carolien A.E. Koks1 , Steven De

Monoclonal antibody

Monoclonal antibody

Oncolytic Virotherapy - Mayo Clinic (2014)

Oncolytic Virotherapy - Mayo Clinic (2014)

A Comparison of the Immunostimulatory Effects of ...

A Comparison of the Immunostimulatory Effects of ...

Serum Albumin as a Carrier of Immunostimulatory ...

Serum Albumin as a Carrier of Immunostimulatory ...

Combined immunostimulatory monoclonal antibodies extend ......2013/09/12  · OVA peptides (described in supplementary methods) for 48h (OVA257-264 and OVA323-339, respectively). 2x10

Combined immunostimulatory monoclonal antibodies extend ......2013/09/12  · OVA peptides (described in supplementary methods) for 48h (OVA257-264 and OVA323-339, respectively). 2x10

Combined immunostimulatory monoclonal antibodies extend ...clincancerres.aacrjournals.org/content/clincanres/early/2013/09/12/... · Combined immunostimulatory monoclonal antibodies

Combined immunostimulatory monoclonal antibodies extend ...clincancerres.aacrjournals.org/content/clincanres/early/2013/09/12/... · Combined immunostimulatory monoclonal antibodies

Route of antigen delivery impacts the immunostimulatory ... · immunostimulatory activity of dendritic cell-based ... sinase (Fig. 3a, right ... Route of antigen delivery impacts

Route of antigen delivery impacts the immunostimulatory ... · immunostimulatory activity of dendritic cell-based ... sinase (Fig. 3a, right ... Route of antigen delivery impacts

Immunostimulatory capacity of dental casting alloys on ... 5.pdf · CHAPTER 5 Immunostimulatory capacity of dental casting alloys on endotoxin responsiveness Dessy Rachmawati1,2,1

Immunostimulatory capacity of dental casting alloys on ... 5.pdf · CHAPTER 5 Immunostimulatory capacity of dental casting alloys on endotoxin responsiveness Dessy Rachmawati1,2,1

Cavatak Oxford Virotherapy Symposium talk

Cavatak Oxford Virotherapy Symposium talk

The Immunostimulatory Capacity of Nontypeable Haemophilus ...

The Immunostimulatory Capacity of Nontypeable Haemophilus ...

Combined Immunostimulatory Monoclonal Antibodies Extend ...clincancerres.aacrjournals.org/content/clincanres/19/22/6151.full.pdf · Cancer Therapy: Preclinical Combined Immunostimulatory

Combined Immunostimulatory Monoclonal Antibodies Extend ...clincancerres.aacrjournals.org/content/clincanres/19/22/6151.full.pdf · Cancer Therapy: Preclinical Combined Immunostimulatory

CURRÍCULO DEL INVESTIGADOR - unav · 2021. 4. 26. · CURRÍCULO DEL INVESTIGADOR - UNIVERSIDAD DE NAVARRA anti-PD1 and anti-CD137 immunostimulatory monoclonal antibodies Título

CURRÍCULO DEL INVESTIGADOR - unav · 2021. 4. 26. · CURRÍCULO DEL INVESTIGADOR - UNIVERSIDAD DE NAVARRA anti-PD1 and anti-CD137 immunostimulatory monoclonal antibodies Título

Interferon and Virotherapy Casey, Kyle, Mark, Wyt.

Interferon and Virotherapy Casey, Kyle, Mark, Wyt.